VSA VisionSys AI absorbed the week's most savage short attack. SI exploded 248 points to 383% as bears swarmed the micro-cap AI name. JEM 707 Cayman Holdings saw SI jump 60 points to 66% in seven days showing rapid accumulation.
Psychedelic stocks faced bearish pressure despite Trump's deregulation order boosting shares. ENVB Enveric Biosciences SI surged 31 points to 34% last week. CMND Clearmind Medicine climbed 30 points to 32%. PBM Psyence Biomedical rose 28 points to 31% as shorts positioned against the rally.
CMPS COMPASS Pathways held 16% SI on $859M market cap. FT reported the UK biotech jumped to two-year highs following the executive order. Bears remained skeptical of sector momentum.
QNCX Quince Therapeutics topped absolute SI charts at 183% with 39-point weekly surge. The $7M biotech crashed 96% in three months yet drew massive short bets. Cost to borrow hit 145% showing extreme crowding.
KALV KalVista Pharmaceuticals held steady at 69% SI. The $1B biotech absorbed minimal change suggesting established positioning. HIMS Hims & Hers saw SI edge up to 36% as telehealth names drew scrutiny.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
